BG102266A - Method for the preparation of solid batched forms having very low doses of the medicamentous form - Google Patents

Method for the preparation of solid batched forms having very low doses of the medicamentous form

Info

Publication number
BG102266A
BG102266A BG102266A BG10226698A BG102266A BG 102266 A BG102266 A BG 102266A BG 102266 A BG102266 A BG 102266A BG 10226698 A BG10226698 A BG 10226698A BG 102266 A BG102266 A BG 102266A
Authority
BG
Bulgaria
Prior art keywords
forms
batched
preparation
solid
low doses
Prior art date
Application number
BG102266A
Other languages
Bulgarian (bg)
English (en)
Inventor
James NAPPER
Karen O'BRIEN
Sultan MANEK
Rajinder Kumar
Julia LOUDON
Michael Clark
Neil Mortimer
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9515624.6A external-priority patent/GB9515624D0/en
Priority claimed from GBGB9606684.0A external-priority patent/GB9606684D0/en
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of BG102266A publication Critical patent/BG102266A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BG102266A 1995-07-29 1998-02-20 Method for the preparation of solid batched forms having very low doses of the medicamentous form BG102266A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9515624.6A GB9515624D0 (en) 1995-07-29 1995-07-29 Novel process
GBGB9606684.0A GB9606684D0 (en) 1996-03-29 1996-03-29 Novel process
PCT/EP1996/003326 WO1997004750A2 (en) 1995-07-29 1996-07-29 Process for preparing solid dosage forms of very low-dose drugs

Publications (1)

Publication Number Publication Date
BG102266A true BG102266A (en) 1998-10-30

Family

ID=26307485

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102266A BG102266A (en) 1995-07-29 1998-02-20 Method for the preparation of solid batched forms having very low doses of the medicamentous form

Country Status (25)

Country Link
EP (1) EP0841902A2 (xx)
JP (1) JPH11510493A (xx)
KR (1) KR19990035972A (xx)
CN (1) CN1196677A (xx)
AP (1) AP858A (xx)
AR (1) AR004178A1 (xx)
AU (1) AU716961B2 (xx)
BG (1) BG102266A (xx)
BR (1) BR9609804A (xx)
CA (1) CA2228048A1 (xx)
CZ (1) CZ24798A3 (xx)
DZ (1) DZ2077A1 (xx)
EA (2) EA000740B1 (xx)
HU (1) HUP9900521A3 (xx)
IL (1) IL122897A0 (xx)
MA (1) MA23953A1 (xx)
MX (1) MX9800809A (xx)
NO (1) NO980384L (xx)
NZ (1) NZ315632A (xx)
OA (1) OA10659A (xx)
PL (1) PL325242A1 (xx)
SK (1) SK11098A3 (xx)
TR (1) TR199800156T1 (xx)
UY (1) UY24297A1 (xx)
WO (1) WO1997004750A2 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9619074D0 (en) * 1996-09-12 1996-10-23 Smithkline Beecham Plc Composition
CA2323177A1 (en) 1998-03-11 1999-09-16 Susan Marie Milosovich Composition
FR2796840B1 (fr) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
AU2742102A (en) 2000-12-14 2002-06-24 Ortho Mcneil Pharm Inc Steroid hormone products and methods for preparing them
US20070202179A1 (en) * 2004-04-09 2007-08-30 FAULKNER Patrick Low Dose Pharmaceutical Products

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4489026A (en) * 1982-09-07 1984-12-18 The Upjohn Company Process for preparing solid unit dosage forms of ultra-low dose drugs
JPS5970614A (ja) * 1982-10-14 1984-04-21 Asahi Chem Ind Co Ltd 微量主薬系湿式固形製剤方法
US4898736A (en) * 1988-03-09 1990-02-06 Merck & Co., Inc. Method for tablet preparation
ES2219636T3 (es) * 1989-04-13 2004-12-01 Beecham Group P.L.C. Nuevos compuestos.
ZA939565B (en) * 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for preparing low dose pharmaceutical products.

Also Published As

Publication number Publication date
NO980384D0 (no) 1998-01-28
JPH11510493A (ja) 1999-09-14
AP9801170A0 (en) 1998-01-31
SK11098A3 (en) 1998-07-08
BR9609804A (pt) 1999-07-06
HUP9900521A2 (hu) 1999-06-28
AR004178A1 (es) 1998-11-04
IL122897A0 (en) 1998-08-16
WO1997004750A3 (en) 1997-03-27
EA199800179A1 (ru) 1998-10-29
EP0841902A2 (en) 1998-05-20
EA000740B1 (ru) 2000-02-28
CA2228048A1 (en) 1997-02-13
NZ315632A (en) 1999-11-29
AP858A (en) 2000-07-12
EA199901055A1 (ru) 2000-06-26
MX9800809A (es) 1998-04-30
WO1997004750A2 (en) 1997-02-13
CN1196677A (zh) 1998-10-21
MA23953A1 (fr) 1997-04-01
AU716961B2 (en) 2000-03-09
TR199800156T1 (xx) 1998-04-21
KR19990035972A (ko) 1999-05-25
NO980384L (no) 1998-03-26
OA10659A (en) 2002-09-18
AU6738496A (en) 1997-02-26
DZ2077A1 (fr) 2002-07-22
PL325242A1 (en) 1998-07-06
HUP9900521A3 (en) 2001-04-28
UY24297A1 (es) 1997-01-23
CZ24798A3 (cs) 1998-06-17

Similar Documents

Publication Publication Date Title
MX9700081A (es) Composiciones farmaceuticas de tacrina.
GEP20032925B (en) Benzothiepines Having Activity As Inhibitors of Ileal Bile Acid Transport and Taurocholate Uptake
WO1994027589A3 (en) Antidepressant dosage form
HU900118D0 (en) Process for preparation of new cyclic amine-derivatives and for manufacturing of pharmaceutical compositions containing these compounds as active ingredient
AU4515985A (en) New tetrapyrrole therapeutic agents
CA2068324A1 (en) Metal-peptide compositions and methods for stimulating hair growth
HUT71417A (en) Oral pharmaceutical preparation containing a salt of morphine and process for producing its
ZA894728B (en) A new pharmaceutical formulation as well as a process for its preparation
FR2698788B1 (fr) Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
PT86186A (en) Process for the preparation of benzimidazol derivatives and of pharmaceutical compositions containing the same
UA35604C2 (uk) Фармацевтична композиція з антидепресивною активністю
HU883863D0 (en) Process for the preparation of producing and/or portionly form of therapeutical agents
EP0137543A3 (en) Pharmaceutical composition for the therapy of peripheral arteriopathies
ES2026304A6 (es) Procedimiento de fabricacion de una forma de dosificacion de nicardipina.
GR3036774T3 (en) Compositions containing G-CSF and TNF binding protein.
EP0414772A4 (en) Method for treating acne
HUT38097A (en) Process for preparing substituted benzopyrans and pharmaceutical compositions containing them as active substances
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
BG102266A (en) Method for the preparation of solid batched forms having very low doses of the medicamentous form
HU895241D0 (en) Process for the preparation of substituted 1,3,5-triazin-trione derivatives and pharmaceutical compositions containing said compounds as active ingredient
JPS6483020A (en) Medicinal composition for preventing or treating aids
EP0652755A1 (en) THERAPEUTIC USE OF PHOSPHORYL-L-SERINE-N-ACYL-SPHINGOSINE.
HUT49320A (en) Process for producing ornithine derivatives and pharmaceutical compositions containing them as active components
JPS6471814A (en) Useikokashooshochisurutamenoiyakusoseibutsu
ES2065855A1 (es) Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.